1. Home
  2. Labeler Index
  3. Taro Pharmaceuticals U.s.a., Inc.
  4. 51672-1308
  5. NDC Package Code: 51672-1308-3 Clotrimazole And Betamethasone Dipropionate

NDC Package 51672-1308-3 Clotrimazole And Betamethasone Dipropionate

Lotion Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51672-1308-3
Package Description:
1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
Product Code:
51672-1308
Proprietary Name:
Clotrimazole And Betamethasone Dipropionate
Non-Proprietary Name:
Clotrimazole And Betamethasone Dipropionate
Substance Name:
Betamethasone Dipropionate; Clotrimazole
Usage Information:
Clotrimazole and betamethasone dipropionate lotion is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes and Trichophyton rubrum. Effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. The efficacy of clotrimazole and betamethasone dipropionate lotion for the treatment of infections caused by zoophilic dermatophytes (e.g., Microsporum canis) has not been established.
11-Digit NDC Billing Format:
51672130803
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 308715 - clotrimazole 1 % / betamethasone dipropionate 0.05 % Topical Lotion
  • RxCUI: 308715 - betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Lotion
  • RxCUI: 308715 - betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / clotrimazole 1 % Topical Lotion
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Taro Pharmaceuticals U.s.a., Inc.
    Dosage Form:
    Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • BETAMETHASONE DIPROPIONATE .5 mg/mL
  • CLOTRIMAZOLE 10 mg/mL
    • Pharmacologic Class(es):
  • Azole Antifungal - [EPC] (Established Pharmacologic Class)
  • Azoles - [CS]
  • Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
  • Corticosteroid - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA076493
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    07-28-2004
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51672-1308-3?

    The NDC Packaged Code 51672-1308-3 is assigned to a package of 1 bottle in 1 carton / 30 ml in 1 bottle of Clotrimazole And Betamethasone Dipropionate, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. The product's dosage form is lotion and is administered via topical form.

    Is NDC 51672-1308 included in the NDC Directory?

    Yes, Clotrimazole And Betamethasone Dipropionate with product code 51672-1308 is active and included in the NDC Directory. The product was first marketed by Taro Pharmaceuticals U.s.a., Inc. on July 28, 2004 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 51672-1308-3?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 51672-1308-3?

    The 11-digit format is 51672130803. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151672-1308-35-4-251672-1308-03